NPI: 1689664179 · HINTON, WV 25951 · Critical Access Hospital · NPI assigned 10/26/2005
Authorized official HARRIS, HOLLIE controls 20+ related entities in our dataset. Read more
| Authorized Official | HARRIS, HOLLIE (PRESIDENT AND CEO) |
| NPI Enumeration Date | 10/26/2005 |
Other providers sharing the same authorized official: HARRIS, HOLLIE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 32,987 | $1.47M |
| 2019 | 13,919 | $654K |
| 2020 | 29,151 | $1.66M |
| 2021 | 29,144 | $1.22M |
| 2022 | 13,157 | $437K |
| 2023 | 11,839 | $458K |
| 2024 | 8,126 | $299K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 4,065 | 3,584 | $649K |
| 80053 | Comprehensive metabolic panel | 14,336 | 11,696 | $535K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 4,834 | 4,280 | $402K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 758 | 634 | $392K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,325 | 12,781 | $356K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,767 | 1,457 | $307K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,479 | 3,122 | $213K |
| 70450 | Computed tomography, head or brain; without contrast material | 777 | 650 | $197K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,826 | 4,438 | $196K |
| 80061 | Lipid panel | 3,693 | 3,392 | $191K |
| 36415 | Collection of venous blood by venipuncture | 13,189 | 9,402 | $185K |
| 84484 | 3,806 | 2,547 | $130K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2,030 | 1,888 | $118K |
| 71046 | Radiologic examination, chest; 2 views | 2,158 | 1,783 | $116K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2,054 | 587 | $115K |
| 71045 | Radiologic examination, chest; single view | 2,527 | 2,084 | $93K |
| 81001 | 4,236 | 3,528 | $92K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1,109 | 647 | $89K |
| 83735 | 3,130 | 2,490 | $85K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,238 | 1,121 | $83K |
| 82150 | 1,065 | 837 | $80K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,278 | 1,024 | $80K |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,474 | 1,890 | $78K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,841 | 2,523 | $73K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,350 | 3,103 | $72K |
| 82553 | 1,927 | 1,329 | $70K | |
| G0378 | Hospital observation service, per hour | 443 | 172 | $60K |
| 87040 | 861 | 592 | $55K | |
| 97035 | 1,245 | 378 | $53K | |
| 83690 | 1,170 | 930 | $51K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,864 | 1,493 | $50K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,198 | 983 | $49K |
| 83880 | 1,346 | 978 | $48K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,700 | 1,468 | $47K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 123 | 94 | $46K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,485 | 1,332 | $42K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,083 | 813 | $41K |
| 82550 | 1,656 | 1,100 | $41K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 605 | 231 | $41K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 966 | 823 | $39K |
| 72100 | 574 | 512 | $39K | |
| 83605 | 907 | 755 | $35K | |
| 85730 | 560 | 451 | $30K | |
| 85610 | 930 | 704 | $26K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 28 | 25 | $25K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 264 | 238 | $23K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 392 | 127 | $23K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,957 | 3,538 | $21K |
| 82607 | 364 | 326 | $18K | |
| 84703 | 384 | 308 | $17K | |
| 93041 | 870 | 769 | $17K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 522 | 407 | $17K |
| 73030 | 229 | 196 | $16K | |
| 99218 | 32 | 30 | $16K | |
| 73564 | 167 | 146 | $15K | |
| 87186 | 255 | 216 | $13K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 404 | 316 | $13K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 19 | 12 | $12K |
| 84439 | 261 | 249 | $11K | |
| 73630 | 150 | 131 | $9K | |
| 81025 | 233 | 212 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 444 | 364 | $8K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 567 | 450 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 291 | 189 | $8K |
| 87077 | 169 | 146 | $8K | |
| 97162 | 150 | 122 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,517 | 1,387 | $7K |
| 93017 | 19 | 12 | $6K | |
| 97014 | 129 | 40 | $5K | |
| 74018 | 93 | 78 | $5K | |
| 87076 | 190 | 167 | $5K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 112 | 75 | $4K |
| 82803 | 73 | 39 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 439 | 269 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 152 | 124 | $4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 177 | 166 | $3K |
| 81002 | 176 | 156 | $3K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 19 | 12 | $3K |
| 82565 | 152 | 109 | $3K | |
| A9270 | Non-covered item or service | 763 | 338 | $3K |
| 84145 | 100 | 70 | $3K | |
| 36600 | 90 | 51 | $3K | |
| 73610 | 44 | 39 | $2K | |
| 85378 | 157 | 135 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 77 | 67 | $2K |
| 96376 | 79 | 25 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 109 | 50 | $2K |
| 80051 | 61 | 38 | $2K | |
| 85652 | 61 | 55 | $2K | |
| 73130 | 31 | 29 | $2K | |
| 82746 | 24 | 24 | $2K | |
| 84520 | 83 | 57 | $1K | |
| 94760 | 79 | 29 | $1K | |
| 85379 | 17 | 12 | $1K | |
| 87449 | 16 | 16 | $1K | |
| 86038 | 14 | 13 | $1K | |
| 84481 | 12 | 12 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 14 | 12 | $915.50 |
| 84550 | 13 | 13 | $806.57 | |
| 87631 | 12 | 12 | $754.77 | |
| 87070 | 16 | 14 | $732.80 | |
| 86200 | 14 | 13 | $495.18 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 35 | 32 | $371.53 |
| 84153 | 14 | 12 | $335.36 |